are glp 1 compounds going away Our first topic in The Pharmacy Gray Zone series covers GLP-1 agonists. This class continues to reshape healthcare and highlight some of the most complex challenges we face across pharmacy practice. From The GLP-1 drug shortage is

In addition, NE is a critical regulator of hippocampal synaptic plasticity, and its release can modulate long-lasting changes in synaptic efficacy on the basis of LTP and LTD, thereby contributing to memory consolidation and storage (Katsuki et al., 1997

Laparoscopy is an invasive surgery

Autoimmune Root Cause: Inflammation vs

Current advantages in the application of microencapsulation in functional bread development

More Medications Mean More Choice Now that there are multiple GLP-1 drugs for obesity, including more than one pill for people with an aversion to needles, patients can really make a choice based on whats most convenient and affordable and achieve meaningful weight loss with any option they select, Jay says

Benefits for 2025 and Beyond As healthcare costs continue to rise, employers are trying to balance the need to take care of their workers with the need to keep costs under control